No 'Safe Harbor' For Gene Therapy Found In Hatch-Waxman
By Andrew Karpan · January 4, 2022, 9:44 PM EST
A Delaware federal judge told Massachusetts biotechnology company Sarepta on Tuesday that it could not use the "safe harbor" provisions of the Hatch-Waxman Act to protect a gene therapy it is...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login